Anatomical location of metastatic lymph nodes: an indispensable prognostic factor for gastric cancer patients who underwent curative resection

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. Cancer J Clin. 2015; 65:87–108.
   PubMed Web of Science ®Google Scholar
• Marrelli D, Polom K, de Manzoni G, et al. Multimodal treatment of gastric cancer in the west: Where are we going? World J Gastroenterol. 2015; 21:7954–7969.
   PubMed Web of Science ®Google Scholar
• Dikken JL, Jansen EP, Cats A, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. JCO. 2010; 28:2430–2436.
   PubMed Web of Science ®Google Scholar
• Park CH, Song KY, Kim SN. Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surgical Oncol. 2008; 34:36–41.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. WJG. 2014;20:3967–3975.
   PubMed Web of Science ®Google Scholar
• Zuo CH, Xie H, Liu J, et al. Characterization of lymph node metastasis and its clinical significance in the surgical treatment of gastric cancer. Mol Clin Oncol. 2014;2:821–826.
   PubMedGoogle Scholar
• Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–123.
   PubMed Web of Science ®Google Scholar
• Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077–3079.
   PubMed Web of Science ®Google Scholar
• Deng J, Zhang R, Pan Y, et al. Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the tumor-node-metastasis (TNM) classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China. Surgery. 2014;156:64–74.
   PubMed Web of Science ®Google Scholar
• Hu X, Cao L, Yu Y. Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7(th) edition and JCGS 13(th) edition N-classification systems. Chin J Cancer Res. 2014;26:596–601.
   PubMed Web of Science ®Google Scholar
• Deng J, Liang H, Sun D, et al. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol. 2010;17:1259–1266.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Ochiai T, Suzuki T, et al. Superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery. 2000;127:129–135.
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Choi YY, An JY, et al. Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study. BMC Cancer. 2015;15:943.
   PubMed Web of Science ®Google Scholar
• Coburn NG, Swallow CJ, Kiss A, et al. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107:2143–2151.
   PubMed Web of Science ®Google Scholar
• Son T, Hyung WJ, Kim JW, et al. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis. Ann Surg Oncol. 2014;21:899–907.
   PubMed Web of Science ®Google Scholar
• Choi YY, An JY, Katai H, et al. A lymph node staging system for gastric cancer: a hybrid type based on topographic and numeric systems. PLoS One. 2016;11:e0149555.
   PubMed Web of Science ®Google Scholar
• Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–449.
   PubMed Web of Science ®Google Scholar
• Kunisaki C, Shimada H, Nomura M, et al. Comparative evaluation of gastric carcinoma staging: Japanese classification versus new American joint committee on cancer/international union against cancer classification. Ann Surg Oncol. 2004;11:203–206.
   PubMed Web of Science ®Google Scholar
• Hidaka H, Eto T, Maehara N, et al. Comparative effect of lymph node metastasis classified by the anatomical site or by the number of nodes involved on prognosis of patients with gastric cancer. Hepatogastroenterology. 2008;55:2269–2272.
   PubMedGoogle Scholar
• Pan Y, Liang H, Xue Q, et al. [Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2008;30:376–380.
   PubMedGoogle Scholar
• Ikeguchi M, Murakami D, Kanaji S, et al. Lymph node metastasis of gastric cancer: comparison of Union International Contra Cancer and Japanese systems. ANZ J Surg. 2004;74:852–854.
   PubMed Web of Science ®Google Scholar
• Chen J, Chen C, He Y, et al. A new pN staging system based on both the number and anatomic location of metastatic lymph nodes in gastric cancer. J Gastrointest Surg. 2014;18:2080–2088.
   PubMed Web of Science ®Google Scholar
• Galizia G, Lieto E, Auricchio A, et al. Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: a western experience. PLoS One. 2017;12:e0173619.
   PubMed Web of Science ®Google Scholar
• Park SS, Ryu JS, Min BW, et al. Impact of skip metastasis in gastric cancer. ANZ J Surg. 2005;75:645–649.
   PubMed Web of Science ®Google Scholar
• Saito H, Tsujitani S, Ikeguchi M. Clinical significance of skip metastasis in patients with gastric cancer. Gastric Cancer. 2007;10:87–91.
   PubMed Web of Science ®Google Scholar
• Kim DH, Choi MG, Noh JH, et al. Clinical significance of skip lymph node metastasis in gastric cancer patients. Eur J Surgical Oncol. 2015;41:339–345.
   PubMed Web of Science ®Google Scholar
• Choi YY, An JY, Guner A, et al. Skip lymph node metastasis in gastric cancer: is it skipping or skipped? Gastric Cancer. 2016;19:206–215.
   PubMed Web of Science ®Google Scholar
• Wong J, Rahman S, Saeed N, et al. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg. 2013;17:2059–2066.
   PubMed Web of Science ®Google Scholar
• Sun Z, Xu Y, Li de M, et al. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer. 2010;116:2571–2580.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li C, Y D, et al. Prognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection. Oncotarget. 2017;8:70841–70846.
   PubMed Web of Science ®Google Scholar
• Lee JW, Ali B, Park CH, et al. Different lymph node staging systems in patients with gastric cancer from Korean: what is the best prognostic assessment tool?. Medicine (Baltimore). 2016;95:e3860
   PubMed Web of Science ®Google Scholar
• Lee SY, Hwang I, Park YS, et al. Metastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes? Int J Oncol. 2010;36:1461–1467.
   PubMed Web of Science ®Google Scholar
• Wang X, Appleby DH, Zhang X, et al. Comparison of three lymph node staging schemes for predicting outcome in patients with gastric cancer. Br J Surg. 2013;100:505–514.
   PubMed Web of Science ®Google Scholar